Cartesian Therapeutics, Inc. Operating Income
Cartesian Therapeutics, Inc. (RNAC) reported Operating Income of -$29.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Cartesian Therapeutics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$29.16M.
- Cartesian Therapeutics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$26.50M.
- Cartesian Therapeutics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$78.64M.
- Cartesian Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$21.07M.
- Cartesian Therapeutics, Inc. operating income (loss) for fiscal 2025 was -$143.41M.
- Cartesian Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$43.90M.
- Cartesian Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$86.42M, a 694.41% decline from fiscal 2022.
- Cartesian Therapeutics, Inc. operating income (loss) for fiscal 2022 was $14.54M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$29.16M 10-Q · filed 2026-08-06 | -$55.65M 10-Q · filed 2026-08-06 | -$134.29M derived: sum of 3 quarters · filed 2026-08-06 | -$155.36M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$26.50M 10-Q · filed 2026-04-30 | -$105.14M derived: sum of 2 quarters · filed 2026-04-30 | -$126.20M derived: sum of 3 quarters · filed 2026-04-30 | -$148.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$78.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$99.70M derived: sum of 2 quarters · filed 2026-03-09 | -$121.52M derived: sum of 3 quarters · filed 2026-08-06 | -$143.41M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$21.07M 10-Q · filed 2025-11-06 | -$42.88M derived: sum of 2 quarters · filed 2026-08-06 | -$64.77M 10-Q · filed 2025-11-06 | -$91.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$21.81M 10-Q · filed 2026-08-06 | -$43.70M 10-Q · filed 2026-08-06 | -$70.43M derived: sum of 3 quarters · filed 2026-08-06 | -$88.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$21.89M 10-Q · filed 2026-04-30 | -$48.62M derived: sum of 2 quarters · filed 2026-04-30 | -$66.19M derived: sum of 3 quarters · filed 2026-04-30 | -$52.44M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$26.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$44.31M derived: sum of 2 quarters · filed 2026-03-09 | -$30.55M derived: sum of 3 quarters · filed 2026-03-09 | -$43.90M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$17.57M 10-Q · filed 2025-11-06 | -$3.82M derived: sum of 2 quarters · filed 2025-11-06 | -$17.17M 10-Q · filed 2025-11-06 | -$53.50M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $13.76M 10-Q · filed 2025-08-07 | $409.00K 10-Q · filed 2025-08-07 | -$35.92M derived: sum of 3 quarters · filed 2025-08-07 | -$48.99M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$13.35M 10-Q · filed 2025-05-08 | -$49.68M derived: sum of 2 quarters · filed 2025-05-08 | -$62.74M derived: sum of 3 quarters · filed 2025-05-08 | -$81.38M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$36.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$49.40M derived: sum of 2 quarters · filed 2025-03-13 | -$68.03M derived: sum of 3 quarters · filed 2025-03-13 | -$86.42M 10-K · filed 2025-03-13 |
| 2023-09-30 | -$13.06M 10-Q · filed 2024-11-07 | -$31.70M derived: sum of 2 quarters · filed 2024-11-07 | -$50.08M 10-Q · filed 2024-11-07 | -$58.58M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$18.64M 10-Q · filed 2024-08-08 | -$37.02M 10-Q · filed 2024-08-08 | -$45.52M derived: sum of 3 quarters · filed 2024-08-08 | -$47.11M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$18.38M 10-Q · filed 2024-05-08 | -$26.88M derived: sum of 2 quarters · filed 2024-05-08 | -$28.48M derived: sum of 3 quarters · filed 2024-05-08 | -$14.62M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$10.10M derived: sum of 2 quarters · filed 2024-03-07 | $3.77M derived: sum of 3 quarters · filed 2024-03-07 | $14.54M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$1.60M 10-Q · filed 2023-11-13 | $12.26M derived: sum of 2 quarters · filed 2023-11-13 | $23.03M 10-Q · filed 2023-11-13 | $27.11M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $13.86M 10-Q · filed 2023-08-17 | $24.63M 10-Q · filed 2023-08-17 | $28.71M derived: sum of 3 quarters · filed 2024-03-07 | $26.74M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $10.77M 10-Q · filed 2023-05-04 | $14.85M derived: sum of 2 quarters · filed 2024-03-07 | $12.88M derived: sum of 3 quarters · filed 2024-03-07 | $13.33M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $2.11M derived: sum of 2 quarters · filed 2024-03-07 | $2.56M derived: sum of 3 quarters · filed 2024-03-07 | -$4.60M 10-K · filed 2024-03-07 |
| 2021-09-30 | -$1.97M 10-Q · filed 2022-11-03 | -$1.52M derived: sum of 2 quarters · filed 2022-11-03 | -$8.68M 10-Q · filed 2022-11-03 | -$16.57M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $452.00K 10-Q · filed 2022-08-08 | -$6.71M 10-Q · filed 2022-08-08 | -$14.60M derived: sum of 3 quarters · filed 2023-03-02 | -$28.34M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | -$7.16M 10-Q · filed 2022-05-05 | -$15.06M derived: sum of 2 quarters · filed 2023-03-02 | -$28.79M derived: sum of 3 quarters · filed 2023-03-02 | -$45.16M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | -$7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$21.63M derived: sum of 2 quarters · filed 2023-03-02 | -$38.00M derived: sum of 3 quarters · filed 2023-03-02 | -$56.82M 10-K · filed 2023-03-02 |
| 2020-09-30 | -$13.73M 10-Q · filed 2021-11-09 | -$30.10M derived: sum of 2 quarters · filed 2021-11-09 | -$48.92M 10-Q · filed 2021-11-09 | -$61.49M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | -$16.37M 10-Q · filed 2021-08-12 | -$35.19M 10-Q · filed 2021-08-12 | -$47.76M derived: sum of 3 quarters · filed 2022-03-10 | -$59.55M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | -$18.82M 10-Q · filed 2021-05-13 | -$31.39M derived: sum of 2 quarters · filed 2022-03-10 | -$43.19M derived: sum of 3 quarters · filed 2022-03-10 | -$59.42M derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | -$12.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$24.36M derived: sum of 2 quarters · filed 2022-03-10 | -$40.60M derived: sum of 3 quarters · filed 2022-03-10 | -$52.45M 10-K · filed 2022-03-10 |
| 2019-09-30 | -$11.79M 10-Q · filed 2020-11-05 | -$28.03M derived: sum of 2 quarters · filed 2020-11-05 | -$39.88M 10-Q · filed 2020-11-05 | -$54.38M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | -$16.23M 10-Q · filed 2020-08-06 | -$28.09M 10-Q · filed 2020-08-06 | -$42.59M derived: sum of 3 quarters · filed 2021-03-12 | -$58.53M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | -$11.86M 10-Q · filed 2020-05-07 | -$26.36M derived: sum of 2 quarters · filed 2021-03-12 | -$42.30M derived: sum of 3 quarters · filed 2021-03-12 | -$61.06M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | -$14.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$30.44M derived: sum of 2 quarters · filed 2021-03-12 | -$49.21M derived: sum of 3 quarters · filed 2021-03-12 | -$65.02M 10-K · filed 2021-03-12 |
| 2018-09-30 | -$15.94M 10-Q · filed 2019-11-08 | -$34.71M derived: sum of 2 quarters · filed 2019-11-08 | -$50.52M 10-Q · filed 2019-11-08 | -$69.80M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$18.77M 10-Q · filed 2019-08-08 | -$34.58M 10-Q · filed 2019-08-08 | -$53.86M derived: sum of 3 quarters · filed 2020-03-12 | -$67.71M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$15.81M 10-Q · filed 2019-05-09 | -$35.09M derived: sum of 2 quarters · filed 2020-03-12 | -$48.94M derived: sum of 3 quarters · filed 2020-03-12 | -$64.81M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$19.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$33.13M derived: sum of 2 quarters · filed 2020-03-12 | -$49.00M derived: sum of 3 quarters · filed 2020-03-12 | -$63.78M 10-K · filed 2020-03-12 |
| 2017-09-30 | -$13.85M 10-Q · filed 2018-11-08 | -$29.73M derived: sum of 2 quarters · filed 2018-11-08 | -$44.51M 10-Q · filed 2018-11-08 | -$58.37M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | -$15.87M 10-Q · filed 2018-08-08 | -$30.65M 10-Q · filed 2018-08-08 | -$44.51M derived: sum of 3 quarters · filed 2019-03-15 | -$51.98M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | -$14.78M 10-Q · filed 2018-05-09 | -$28.64M derived: sum of 2 quarters · filed 2019-03-15 | -$36.11M derived: sum of 3 quarters · filed 2019-03-15 | -$42.51M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | -$13.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$21.33M derived: sum of 2 quarters · filed 2019-03-15 | -$27.73M derived: sum of 3 quarters · filed 2019-03-15 | -$34.67M 10-K · filed 2019-03-15 |
| 2016-09-30 | -$7.47M 10-Q · filed 2017-11-07 | -$13.87M derived: sum of 2 quarters · filed 2017-11-07 | -$20.81M 10-Q · filed 2017-11-07 | -$27.92M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | -$6.40M 10-Q · filed 2017-08-11 | -$13.34M 10-Q · filed 2017-08-11 | -$20.45M derived: sum of 3 quarters · filed 2018-03-15 | -$26.52M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | -$6.94M 10-Q · filed 2017-05-11 | -$14.05M derived: sum of 2 quarters · filed 2018-03-15 | -$20.12M derived: sum of 3 quarters · filed 2018-03-15 | -$26.43M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | -$7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$13.18M derived: sum of 2 quarters · filed 2018-03-15 | -$19.49M derived: sum of 3 quarters · filed 2018-03-15 | -$25.30M 10-K · filed 2018-03-15 |
| 2015-09-30 | -$6.07M 10-Q · filed 2016-11-10 | -$12.39M derived: sum of 2 quarters · filed 2016-11-10 | -$18.20M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | -$6.32M 10-Q · filed 2016-08-09 | -$12.13M 10-Q · filed 2016-08-09 | ||
| 2014-12-31 | -$15.40M 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |